Skip Navigation, or press ALT and K together and then press enter.Welcome to the OMC website. This site has been developed for both the visually impaired and non visually impaired. If you would like to use the visually impaired version of this site please go to omc.gov.ie/viewtxt.asp, or press ALT and I together and then press enter

Accessibility
Legal Notices
Text Version

Irish Child Health Database - Peer Reviewed Papers

Database Search

Irish Child Health Database » » D » Dexamethasone/adverse effects/economics/ therapeutic use

Dexamethasone/adverse effects/economics/ therapeutic use

Your search returns 1 documents

1. Postnatal dexamethasone: what is the real cost-benefit ratio?

This paper discusses postnatal corticosteroids given early after birth reduce the risk of chronic lung disease in preterm infants but are associated with an approximate doubling of the risk of adverse neurosensory outcomes

Abstract:

Postnatal corticosteroids given early after birth reduce the risk of chronic lung disease in preterm infants but are associated with an approximate doubling of the risk of adverse neurosensory outcomes. Corticosteroids given after 7-10 d of age appear not to have these increased risks of neurosensory sequelae and reduce time on the ventilator. CONCLUSION: Further research is needed to more...

Geography:

Northern Ireland

Acta Paediatr, Vol: 92 Page: 888-9 August 2003
H. L. Halliday

[Preview] [Read]